Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients

This publication has 49 references indexed in Scilit:

• Golgi phosphoprotein 2 in physiology and in diseases
  Cell & Bioscience, 2012
• Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis
  Hepatology International, 2012
• Golgi protein 73 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta- analysis
  BMC Cancer, 2012
• Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival
  Journal of Gastroenterology and Hepatology, 2011
• Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
  Gut, 2010
• AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC
  Journal of Gastroenterology, 2010
• Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece
  European Journal of Internal Medicine, 2008
• A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
  Hepatology, 2003
• Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease
  Hepatology, 2002
• Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
  Seminars in Liver Disease, 1999